-
1
-
-
0022399581
-
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene
-
2999974 10.1126/science.2999974 1:CAS:528:DyaL28XmslKhuw%3D%3D
-
L Coussens TL Yang-Feng YC Liao E Chen A Gray J McGrath PH Seeburg TA Libermann J Schlessinger U Francke 1985 Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene Science 230 1132 1139 2999974 10.1126/science.2999974 1:CAS:528:DyaL28XmslKhuw%3D%3D
-
(1985)
Science
, vol.230
, pp. 1132-1139
-
-
Coussens, L.1
Yang-Feng, T.L.2
Liao, Y.C.3
Chen, E.4
Gray, A.5
McGrath, J.6
Seeburg, P.H.7
Libermann, T.A.8
Schlessinger, J.9
Francke, U.10
-
2
-
-
0022588467
-
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
-
T Yamamoto S Ikawa T Akiyama K Semba N Nomura N Miyajima T Saito K Toyoshima 1986 Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor Nature 319 230 234 3003577 10.1038/319230a0 1:CAS:528:DyaL28XhtVensLY%3D (Pubitemid 16128786)
-
(1986)
Nature
, vol.319
, Issue.6050
, pp. 230-234
-
-
Yamamoto, T.1
Ikawa, S.2
Akiyama, T.3
-
3
-
-
0024651788
-
Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32
-
2565881 10.1016/0888-7543(89)90343-1 1:CAS:528:DyaL1MXit1Knsb8%3D
-
NC Popescu CR King MH Kraus 1989 Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32 Genomics 4 362 366 2565881 10.1016/0888-7543(89)90343-1 1:CAS:528:DyaL1MXit1Knsb8%3D
-
(1989)
Genomics
, vol.4
, pp. 362-366
-
-
Popescu, N.C.1
King, C.R.2
Kraus, M.H.3
-
4
-
-
0026650016
-
Prognostic significance of HER-2 oncoprotein expression in breast cancer: A 30-year follow-up
-
1351537 1:STN:280:DyaK38zgtVCjtw%3D%3D
-
S Toikkanen H Helin J Isola H Joensuu 1992 Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up J Clin Oncol 10 1044 1048 1351537 1:STN:280:DyaK38zgtVCjtw%3D%3D
-
(1992)
J Clin Oncol
, vol.10
, pp. 1044-1048
-
-
Toikkanen, S.1
Helin, H.2
Isola, J.3
Joensuu, H.4
-
5
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
D Slamon B Leyland-Jones S Shak H Fuchs V Paton A Bajamonde W Fleming J Wolter M Pegram J Baselga L Norton 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792 11248153 10.1056/NEJM200103153441101 1:CAS:528: DC%2BD3MXisVGktrc%3D (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
6
-
-
0026718827
-
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
-
1351679 10.1073/pnas.89.12.5321 1:CAS:528:DyaK38XksVGlt70%3D
-
OP Kallioniemi A Kallioniemi W Kurisu A Thor LC Chen HS Smith FM Waldman D Pinkel JW Gray 1992 ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization Proc Natl Acad Sci USA 89 5321 5325 1351679 10.1073/pnas.89.12.5321 1:CAS:528:DyaK38XksVGlt70%3D
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 5321-5325
-
-
Kallioniemi, O.P.1
Kallioniemi, A.2
Kurisu, W.3
Thor, A.4
Chen, L.C.5
Smith, H.S.6
Waldman, F.M.7
Pinkel, D.8
Gray, J.W.9
-
7
-
-
0036161321
-
HER2 testing in patients with breast cancer: Poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization
-
11838648 10.4065/77.2.148
-
EA Perez PC Roche RB Jenkins CA Reynolds KC Halling JN Ingle LE Wold 2002 HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization Mayo Clin Proc 77 148 154 11838648 10.4065/77.2.148
-
(2002)
Mayo Clin Proc
, vol.77
, pp. 148-154
-
-
Perez, E.A.1
Roche, P.C.2
Jenkins, R.B.3
Reynolds, C.A.4
Halling, K.C.5
Ingle, J.N.6
Wold, L.E.7
-
8
-
-
58049212011
-
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard
-
19019764 10.1309/AJCP5UUMFMA5ZKII
-
S Umemura RY Osamura F Akiyama K Honma M Kurosumi H Sasano S Toyoshima H Tsuda J Ruschoff G Sakamoto 2008 What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard Am J Clin Pathol 130 883 891 19019764 10.1309/AJCP5UUMFMA5ZKII
-
(2008)
Am J Clin Pathol
, vol.130
, pp. 883-891
-
-
Umemura, S.1
Osamura, R.Y.2
Akiyama, F.3
Honma, K.4
Kurosumi, M.5
Sasano, H.6
Toyoshima, S.7
Tsuda, H.8
Ruschoff, J.9
Sakamoto, G.10
-
9
-
-
34247363714
-
Standardization of HER2 testing: Results of an international proficiency-testing ring study
-
DOI 10.1038/modpathol.3800774, PII 3800774
-
M Dowsett WM Hanna M Kockx F Penault-Llorca J Ruschoff T Gutjahr K Habben MJ van de Vijver 2007 Standardization of HER2 testing: results of an international proficiency-testing ring study Mod Pathol 20 584 591 17396141 10.1038/modpathol.3800774 (Pubitemid 46632000)
-
(2007)
Modern Pathology
, vol.20
, Issue.5
, pp. 584-591
-
-
Dowsett, M.1
Hanna, W.M.2
Kockx, M.3
Penault-Llorca, F.4
Ruschoff, J.5
Gutjahr, T.6
Habben, K.7
Van De Vijver, M.J.8
-
10
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
DOI 10.1200/JCO.2006.09.2775
-
AC Wolff EH Hammond JN Schwartz KL Hagerty DC Allred RJ Cote M Dowsett PL Fitzqibbons WM Hanna A Langer LM McShane S Paik MD Pegram EA Perez MF Press A Rhodes C Sturqeon SE Taube R Tubbs GH Vance M van de Vijver TM Wheeler DF Hayes 2007 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 118 145 17159189 10.1200/JCO.2006.09.2775 1:CAS:528:DC%2BD2sXht1ejs7Y%3D (Pubitemid 350003059)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.1
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.H.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
Dowsett, M.7
Fitzgibbons, P.L.8
Hanna, W.M.9
Langer, A.10
McShane, L.M.11
Paik, S.12
Pegram, M.D.13
Perez, E.A.14
Press, M.F.15
Rhodes, A.16
Sturgeon, C.17
Taube, S.E.18
Tubbs, R.19
Vance, G.H.20
Van De Vijver, M.21
Wheeler, T.M.22
Hayes, D.F.23
more..
-
11
-
-
70349671836
-
-
Nitta H, Hauss-Weqrzyniak B, Lehrkamp M, Murillo AE, Gaire F, Farrell M, Walk E, Penault-Llorca F, Kurosumi M, Dietel M, Wang L, Loftus M, Pettay J, Tubbs RR, Grogan TM. Diagn Pathol. 2009 (in press).
-
(2009)
Diagn Pathol.
-
-
Nitta, H.1
Hauss-Weqrzyniak, B.2
Lehrkamp, M.3
Murillo, A.E.4
Gaire, F.5
Farrell, M.6
Walk, E.7
Penault-Llorca, F.8
Kurosumi, M.9
Dietel, M.10
Wang, L.11
Loftus, M.12
Pettay, J.13
Tubbs, R.R.14
Grogan, T.M.15
|